Neuroone Medical Technologies is trading at $1.87 (6.2% up) on thin after-hours liquidity and short-term repositioning.

  • The move follows a 7.4% regular-session drop to $1.76.
  • No new earnings, FDA updates, major deals, or analyst calls have been reported so far.
  • Broader indices are mixed and relatively flat, suggesting the move is not driven by macro market direction.